These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15837156)

  • 1. What's new in antibiotics?
    Padmanabhan RA; Larosa SP; Tomecki KJ
    Dermatol Clin; 2005 Apr; 23(2):301-12. PubMed ID: 15837156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
    Scheinfeld N
    J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of linezolid in the treatment of complicated skin and soft tissue infections.
    Peppard WJ; Weigelt JA
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):357-66. PubMed ID: 16771613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel antibacterial agents for skin and skin structure infections.
    Schweiger ES; Weinberg JM
    J Am Acad Dermatol; 2004 Mar; 50(3):331-40; quiz 341-2. PubMed ID: 14988672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Daptomycin--a new antibiotic for the treatment of skin and soft tissue infections].
    Mathiesen L; Midtvedt T; Solberg CO
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2383-4. PubMed ID: 16998552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with recently approved antibiotics.
    Paterson DL
    Curr Opin Pharmacol; 2006 Oct; 6(5):486-90. PubMed ID: 16904377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New drugs; daptomycin].
    van Bronswijk H; Dubois EA; van Dissel JT; Cohen AF
    Ned Tijdschr Geneeskd; 2007 Dec; 151(50):2777-8. PubMed ID: 18232197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
    Jørgen B; Merckoll P; Melby KK
    Scand J Infect Dis; 2007; 39(11-12):1059-62. PubMed ID: 17852934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Daptomycin: revitalizing a former drug due to the need of new active agents against grampositive multiresistant bacterias].
    Hernández Martí V; Romá Sánchez E; Salavert Lletí M; Bosó Ribelles V; Poveda Andrés JL
    Rev Esp Quimioter; 2007 Sep; 20(3):261-76. PubMed ID: 18080024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of antibiotics in dermatologic surgery.
    Robins P; Hsiung S
    J Drugs Dermatol; 2006 Sep; 5(8):780-2. PubMed ID: 16989193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion of antimicrobials used to treat methicillin-resistant Staphylococcus aureus infections during lactation: safety in breastfeeding infants.
    Mitrano JA; Spooner LM; Belliveau P
    Pharmacotherapy; 2009 Sep; 29(9):1103-9. PubMed ID: 19698015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.
    Smith PF; Booker BM; Ogundele AB; Kelchin P
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):255-9. PubMed ID: 15935606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First in a new class of antibiotics.
    FDA Consum; 2003; 37(6):4. PubMed ID: 14983807
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergence and management of drug-resistant enterococcal infections.
    Arias CA; Murray BE
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):637-55. PubMed ID: 18847403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic challenges in the era of antibiotic resistance.
    Lee C
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S197-9. PubMed ID: 19134519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin: rationale and role in the management of skin and soft tissue infections.
    Seaton RA
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii15-23. PubMed ID: 18829721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antimicrobial armamentarium: evaluating current and future treatment options.
    Bosso JA
    Pharmacotherapy; 2005 Oct; 25(10 Pt 2):55S-62S. PubMed ID: 16178676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
    De Cock E; Sorensen S; Levrat F; Besnier JM; Dupon M; Guery B; Duttagupta S
    Med Mal Infect; 2009 May; 39(5):330-40. PubMed ID: 19304423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections.
    Kern WV
    Int J Clin Pract; 2006 Mar; 60(3):370-8. PubMed ID: 16494659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
    Rybak MJ
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.